Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass

被引：0
|
作者：
Takashi Watanabe
Kazuaki Shirota
机构：
[1] Nagoya University School of Medicine,Department of Thoracic Surgery
来源：
The Japanese Journal of Thoracic and Cardiovascular Surgery | 1998年 / 46卷 / 6期
关键词：
Heparin; Cardiopulmonary Bypass; Activate Clotting Time; Heparin Dose; Heparin Concentration;
D O I：
10.1007/BF03250593
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：530 / 530
相关论文
共 50 条
  • [1] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [2] SIGNIFICANCE OF THE WHOLE-BLOOD ACTIVATED CLOTTING TIME IN CARDIOPULMONARY BYPASS
    KESTEVEN, PJ
    PASAOGLU, I
    WILLIAMS, BT
    SAVIDGE, GF
    JOURNAL OF CARDIOVASCULAR SURGERY, 1986, 27 (01): : 85 - 89
  • [3] MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME
    BERG, E
    STENBJERG, S
    ALBRECHTSEN, OK
    JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1979, 11 (06): : 229 - 235
  • [4] Real time measurement of heparin concentration during cardiopulmonary bypass
    Hashimoto, K
    Sasaki, T
    Hachiya, T
    Takakura, H
    Onoguchi, K
    Nagahori, R
    Takeuchi, S
    JOURNAL OF CARDIOVASCULAR SURGERY, 1999, 40 (05): : 645 - 651
  • [5] LACK OF CORRELATION BETWEEN ACTIVATED CLOTTING TIME AND PLASMA HEPARIN DURING CARDIOPULMONARY BYPASS
    CULLIFORD, AT
    GITEL, SN
    STARR, N
    THOMAS, ST
    BAUMANN, FG
    WESSLER, S
    SPENCER, FC
    ANNALS OF SURGERY, 1981, 193 (01) : 105 - 111
  • [6] MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1025 - 1025
  • [7] MEASUREMENT OF THE ACTIVATED CLOTTING TIME (ACT) DURING CARDIOPULMONARY BYPASS IN CHILDREN - IS IT RELEVANT
    HORKAY, F
    MARTIN, P
    SAEED, W
    RAJAH, SM
    WALKER, DR
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1028 - 1028
  • [8] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [9] Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass
    Shirota, K
    Watanabe, T
    Takagi, Y
    Ohara, Y
    Usui, A
    Yasuura, K
    ARTIFICIAL ORGANS, 2000, 24 (01) : 49 - 56
  • [10] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, HC
    YACOUB, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
12345